Yanover, C., Magen-Rimon, R., Voss, E. A., Swerdel, J., Sheahan, A., Hall, N., Park, J., Park, R. W., Lee, K. J., Shin, S. J., Seo, S. I., Lee, K.-J., Falconer, T., Haas, L., Nagy, P., Bowring, M. G., Cook, M., Miller, S., El-Hay, T., … Weisshof, R. (2024). Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08787-x

Choi, B., Church, J., Khoshknabi, D., Jabi, O., & Kiran, R. P. (2024). Outcomes after right-sided colon surgery in Crohn’s disease versus cancer. Techniques in Coloproctology, 28(1). https://doi.org/10.1007/s10151-024-02962-y

Lamichhane, N., Melas, N., Bergqvist, V., Ekholm, N.-P., Olén, O., Ludvigsson, J. F., Hjortswang, H., Marsal, J., Eriksson, C., & Halfvarson, J. (2024). Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 69(6), 2175–2183. https://doi.org/10.1007/s10620-024-08422-9

Sehgal, P., Su, S., Zech, J., Nobel, Y., Luk, L., Economou, I., Shen, B., Lewis, J. D., & Freedberg, D. E. (2023). Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not. Inflammatory Bowel Diseases, 30(4), 594–601. https://doi.org/10.1093/ibd/izad111

Mao, L., Li, Y., Cui, B., Lu, L., Dou, W., Pylypenko, D., Zhu, J., & Li, H. (2024). Multiparametric MRI for Staging of Bowel Inflammatory Activity in Crohn’s Disease with MUSE-IVIM and DCE-MRI: A Preliminary Study. Academic Radiology, 31(3), 880–888. https://doi.org/10.1016/j.acra.2023.08.028

Eriksson, C., Sun, J., Bryder, M., Bröms, G., Everhov, Å. H., Forss, A., Jernberg, T., Ludvigsson, J. F., & Olén, O. (2024). Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics, 59(9), 1122–1133. Portico. https://doi.org/10.1111/apt.17932

Dokmak, A., Sweigart, B., Orekondy, N. S., Jangi, S., Weinstock, J. V., Hamdeh, S., Kochar, G. S., Shen, B., & Levy, A. N. (2023). Efficacy and Safety of Hyperbaric Oxygen Therapy in Fistulizing Crohn’s Disease. Journal of Clinical Gastroenterology, 58(2), 120–130. https://doi.org/10.1097/mcg.0000000000001905

Varma, S., Trudeau, S. J., Li, J., & Freedberg, D. E. (2023). Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series. Inflammatory Bowel Diseases, 30(1), 38–44. https://doi.org/10.1093/ibd/izad035

Uchida, A. M., Garber, J. J., Pyne, A., Peterson, K., Roelstraete, B., Olén, O., Halfvarson, J., & Ludvigsson, J. F. (2023). Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. United European Gastroenterology Journal, 12(1), 34–43. Portico. https://doi.org/10.1002/ueg2.12493

Barnes, E. L., Kayal, M., & Schwartzberg, D. M. (2023). The Rational Use of Advanced Therapies for Inflammatory Conditions of the Pouch. Inflammatory Bowel Diseases, 29(12), 2007–2009. https://doi.org/10.1093/ibd/izad264

Zubrzycka, I., Bogale, K., Stuart, A., Cesaire, M., Walter, V., Dalessio, S., Tinsley, A., Williams, E., Clarke, K., & Coates, M. D. (2023). Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease. International Journal of Colorectal Disease, 38(1). https://doi.org/10.1007/s00384-023-04510-w

Olén, O., Smedby, K. E., Erichsen, R., Pedersen, L., Halfvarson, J., Hallqvist-Everhov, Å., Bryder, N., Askling, J., Ekbom, A., Sachs, M. C., Sørensen, H. T., Ludvigsson, J. F., Olsson, M., Myrelid, P., Hjortswang, H., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., … Karling, P. (2023). Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Clinical Gastroenterology and Hepatology, 21(12), 3132–3142. https://doi.org/10.1016/j.cgh.2023.04.001

Mårild, K., Söderling, J., Axelrad, J., Halfvarson, J., Forss, A., Olén, O., Ludvigsson, J. F., Olsson, M., Myrelid, P., Hjortswang, H., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., Eberhardson, M., Nordenvall, C., Björk, J., Rejler, M., Grip, O., … Karling, P. (2024). Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study. Clinical Gastroenterology and Hepatology, 22(4), 831–846. https://doi.org/10.1016/j.cgh.2023.10.013

Axelrad, J. E., Olén, O., Söderling, J., Roelstraete, B., Khalili, H., Song, M., Faye, A., Eberhardson, M., Halfvarson, J., & Ludvigsson, J. F. (2023). Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden. Journal of Crohn’s and Colitis, 17(9), 1395–1409. https://doi.org/10.1093/ecco-jcc/jjad056

Santiago, P., Coelho-Prabhu, N., Lennon, R., Rui, S., Rajauria, P., Friton, J., Raffals, L. E., Deepali, F., Daoud, N., Farraye, F. A., Tuck, J., Malik, T., Leleiko, N. S., Shapiro, J., Shah, S. A., Sands, B. E., & Ungaro, R. C. (2023). Baseline Clinical Factors Are Associated With Risk of Complications in Crohn’s Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. American Journal of Gastroenterology, 119(1), 147–154. https://doi.org/10.14309/ajg.0000000000002498

D’Antongiovanni, V., Pellegrini, C., Fornai, M., Nemeth, Z. H., Haskó, G., & Antonioli, L. (2023). Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics? Journal of Drug Targeting, 31(7), 693–699. https://doi.org/10.1080/1061186x.2023.2235092

Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Kwinta, B. D., Magro, C. M., & Geskin, L. J. (2023). Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn’s Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. The American Journal of Dermatopathology, 45(8), 572–576. https://doi.org/10.1097/dad.0000000000002470

Chandan, S., Dhindsa, B. S., Khan, S. R., Deliwala, S., Kassab, L. L., Mohan, B. P., Chandan, O. C., Loras, C., Shen, B., & Kochhar, G. S. (2022). Endoscopic Stenting in Crohn’s Disease-related Strictures: A Systematic Review and Meta-analysis of Outcomes. Inflammatory Bowel Diseases, 29(7), 1145–1152. https://doi.org/10.1093/ibd/izac153

Eriksson, C., Söderling, J., Karlqvist, S., Bröms, G., Everhov, Å. H., Bergemalm, D., Ludvigsson, J. F., Olén, O., & Halfvarson, J. (2023). Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn’s Disease. Digestive Diseases and Sciences, 68(7), 3119–3128. https://doi.org/10.1007/s10620-023-07897-2

Wang, K., Olén, O., Emilsson, L., Khalili, H., Halfvarson, J., Song, M., & Ludvigsson, J. F. (2023). Association of inflammatory bowel disease in first‐degree relatives with risk of colorectal cancer: A nationwide case‐control study in Sweden. International Journal of Cancer, 152(11), 2303–2313. Portico. https://doi.org/10.1002/ijc.34470

Liu, J. J., Abraham, B. P., Adamson, P., Barnes, E. L., Brister, K. A., Damas, O. M., Glover, S. C., Hooks, K., Ingram, A., Kaplan, G. G., Loftus, E. V., McGovern, D. P. B., Narain-Blackwell, M., Odufalu, F.-D., Quezada, S., Reeves, V., Shen, B., Stappenbeck, T. S., & Ward, L. (2022). The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases, 29(2), 297–307. https://doi.org/10.1093/ibd/izac124

Forss, A., Clements, M., Myrelid, P., Strid, H., Söderman, C., Wagner, A., Andersson, D., Hjelm, F., Olén, O., Halfvarson, J., & Ludvigsson, J. F. (2022). Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn’s Disease. Digestive Diseases and Sciences, 68(1), 65–76. https://doi.org/10.1007/s10620-022-07501-z

Lee, K. E., Lim, F., Faye, A. S., Shen, B., & Hur, C. (2022). Endoscopic Balloon Dilation Is Cost-Effective for Crohn’s Disease Strictures. Digestive Diseases and Sciences, 67(12), 5462–5471. https://doi.org/10.1007/s10620-022-07420-z

Xu, Z., Chen, J. J., Mei, Q., Li, Y., & Xu, J. (2022). Expression of 5-hydroxytryptamine 7 receptor in intestinal mucosa correlates with the degree of intestinal inflammation in Crohn’s disease. BMC Gastroenterology, 22(1). https://doi.org/10.1186/s12876-022-02513-5

Angistriotis, A., Shen, B., & Kiran, R. P. (2022). Construction of and Conversion to Continent Ileostomy: A Systematic Review. Diseases of the Colon & Rectum, 65(S1), S26–S36. https://doi.org/10.1097/dcr.0000000000002631

Shrestha, S., Brand, J. S., Järås, J., Schoultz, I., Montgomery, S., Askling, J., Ludvigsson, J. F., Olen, O., Halfvarson, J., Olsson, M., Hjortswang, H., Myrelid, P., Bengtsson, J., Strid, H., Andersson, M., Jäghult, S., Eberhardson, M., Nordenvall, C., … Karling, P. (2022). Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden. Journal of Crohn’s and Colitis, 16(10), 1540–1550. https://doi.org/10.1093/ecco-jcc/jjac065

Gupta, N., Lustig, R. H., Andrews, H., Guthery, S. L., Patel, A. S., Gokhale, R., Goyal, A., Siebold, L., Sylvester, F., & Leu, C.-S. (2022). Sex-Specific Pathways Lead to Statural Growth Impairment in Children with Crohn’s Disease. The Journal of Pediatrics, 249, 75-83.e1. https://doi.org/10.1016/j.jpeds.2022.05.041

Lan, N., & Shen, B. (2022). Endoscopic Therapy for Fistulas and Abscesses in Crohn’s Disease. Gastrointestinal Endoscopy Clinics of North America, 32(4), 733–746. https://doi.org/10.1016/j.giec.2022.05.006

Adler, J., Eder, S. J., Gebremariam, A., Moran, C. J., Bass, L. M., Moses, J., Lewis, J. D., Singer, A. A. M., Morhardt, T. L., Picoraro, J. A., Cardenas, V., Zacur, G. M., & Colletti, R. B. (2021). Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease. Inflammatory Bowel Diseases, 28(10), 1537–1542. https://doi.org/10.1093/ibd/izab315

Everhov, Å. H., Erichsen, R., Järås, J., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Ludvigsson, J. F., Sørensen, H. T., & Olén, O. (2022). Colorectal cancer in elderly‐onset inflammatory bowel disease: a 1969–2017 Scandinavian register‐based cohort study. Alimentary Pharmacology & Therapeutics, 56(7), 1168–1182. Portico. https://doi.org/10.1111/apt.17175

Householder, S., & Picoraro, J. A. (2022). Diagnosis and Classification of Fistula from Inflammatory Bowel Disease and Inflammatory Bowel Disease-Related Surgery. Gastrointestinal Endoscopy Clinics of North America, 32(4), 631–650. https://doi.org/10.1016/j.giec.2022.04.003

Faye, A. S., Lee, K. E., Dodson, J., Chodosh, J., Hudesman, D., Remzi, F., Wright, J. D., Friedman, A. M., Shaukat, A., & Wen, T. (2022). Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Alimentary Pharmacology & Therapeutics, 56(7), 1157–1167. Portico. https://doi.org/10.1111/apt.17162

Bakes, D., & Kiran, R. P. (2022). Overview of Common Complications in Inflammatory Bowel Disease Surgery. Gastrointestinal Endoscopy Clinics of North America, 32(4), 761–776. https://doi.org/10.1016/j.giec.2022.05.011

Mårild, K., Söderling, J., Lebwohl, B., Green, P. H. R., Pinto-Sanchez, M. I., Halfvarson, J., Roelstraete, B., Olén, O., & Ludvigsson, J. F. (2022). Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study. American Journal of Gastroenterology, 117(9), 1471–1481. https://doi.org/10.14309/ajg.0000000000001834

Wen, T., Faye, A. S., Lee, K. E., Friedman, A. M., Wright, J. D., Lebwohl, B., & Colombel, J.-F. (2021). Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months. Digestive Diseases and Sciences, 67(9), 4278–4286. https://doi.org/10.1007/s10620-021-06999-z

Everhov, Å. H., Kalman, T. D., Söderling, J., Nordenvall, C., Halfvarson, J., Ekbom, A., Ludvigsson, J. F., Olén, O., & Myrelid, P. (2021). Probability of Stoma in Incident Patients With Crohn’s Disease in Sweden 2003-2019: A Population-based Study. Inflammatory Bowel Diseases, 28(8), 1160–1168. https://doi.org/10.1093/ibd/izab245

Azab, B., Rabab’h, O., Aburizeg, D., Mohammad, H., Dardas, Z., Mustafa, L., Khasawneh, R. A., Awad, H., Hatmal, M. M., & Altamimi, E. (2022). Potential Composite Digenic Contribution of NPC1 and NOD2 Leading to Atypical Lethal Niemann-Pick Type C with Initial Crohn’s Disease-like Presentation: Genotype-Phenotype Correlation Study. Genes, 13(6), 973. https://doi.org/10.3390/genes13060973

Abraham, B., Eksteen, B., Nedd, K., Kale, H., Patel, D., Stephens, J., Shelbaya, A., Chambers, R., & Soonasra, A. (2022). Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study). Advances in Therapy, 39(5), 2109–2127. https://doi.org/10.1007/s12325-022-02104-6

Eberhardson, M., Myrelid, P., Söderling, J. K., Ekbom, A., Everhov, Å. H., Hedin, C. R. H., Neovius, M., Ludvigsson, J. F., & Olén, O. (2022). Tumour necrosis factor inhibitors in Crohn’s disease and the effect on surgery rates. Colorectal Disease, 24(4), 470–483. Portico. https://doi.org/10.1111/codi.16021

Lightner, A. L., Steele, S. R., McMichael, J. P., Jia, X., Qazi, T., Click, B. H., & Church, J. (2022). Pouch Function Over Time and With Advancing Age. Diseases of the Colon & Rectum, 65(2), 254–263. https://doi.org/10.1097/dcr.0000000000002066

Kim, D. J., Tischler, E. H., Kong, R. M., Nehme, F., Dolphin, E. J., Ho, E. S., Lescaille, Y., & Naziri, Q. (2022). Crohn’s disease in total knee arthroplasty patients correlates with increased rates of 90-day and overall postoperative complications and readmissions. The Knee, 34, 238–245. https://doi.org/10.1016/j.knee.2021.12.001

Shen, B., Kochhar, G. S., Rubin, D. T., Kane, S. V., Navaneethan, U., Bernstein, C. N., Cross, R. K., Sugita, A., Schairer, J., Kiran, R. P., Fleshner, P., McCormick, J. T., D’Hoore, A., Shah, S. A., Farraye, F. A., Kariv, R., Liu, X., Rosh, J., Chang, S., … Pardi, D. S. (2022). Treatment of pouchitis, Crohn’s disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. The Lancet Gastroenterology & Hepatology, 7(1), 69–95. https://doi.org/10.1016/s2468-1253(21)00214-4

Zhu, Y., Qian, W., Huang, L., Xu, Y., Guo, Z., Cao, L., Gong, J., Coffey, J. C., Shen, B., Li, Y., & Zhu, W. (2021). Role of Extended Mesenteric Excision in Postoperative Recurrence of Crohn’s Colitis: A Single-Center Study. Clinical and Translational Gastroenterology, 12(10), e00407. https://doi.org/10.14309/ctg.0000000000000407

Ludvigsson, J. F., Holmgren, J., Grip, O., Halfvarson, J., Askling, J., Sachs, M. C., & Olén, O. (2021). Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002–2017. Scandinavian Journal of Gastroenterology, 56(10), 1152–1162. https://doi.org/10.1080/00365521.2021.1924259